Clinical trial
Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation
NCT02796755 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation
- Lead sponsor
- Emory University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2016
- Completion date
- October 24, 2019
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.